» Articles » PMID: 26134517

Lysophosphatidic Acid Increases the Proliferation and Migration of Adipose‑derived Stem Cells Via the Generation of Reactive Oxygen Species

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2015 Jul 3
PMID 26134517
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Phospholipid derivatives, such as lysophosphatidic acid (LPA), exhibit mitogenic effects on mesenchymal stem cells; however, the molecular mechanism underlying this stimulation has yet to be identified. The aims of the present study were as follows: To evaluate the stimulatory effects of LPA on the proliferation and migration of adipose‑derived stem cells (ASCs); to study the association between reactive oxygen species (ROS) and LPA signaling in ASCs; and to investigate the microRNAs upregulated by LPA treatment in ASCs. The results of the present study demonstrated that LPA increased the proliferation and migration of ASCs, and acted as a mitogenic signal via extracellular signal‑regulated kinases 1/2 and the phosphoinositide 3‑kinase/Akt signaling pathways. The LPA1 receptor is highly expressed in ASCs, and pharmacological inhibition of it by Ki16425 significantly attenuated the proliferation and migration of ASCs. In addition, LPA treatment generated ROS via NADPH oxidase 4, and ROS were able to function as signaling molecules to increase the proliferation and migration of ASCs. The induction of ROS by LPA treatment also upregulated the expression of miR‑210. A polymerase chain reaction array assay demonstrated that the expression levels of adrenomedullin and Serpine1 were increased following treatment with LPA. Furthermore, transfection with Serpine1‑specific small interfering RNA attenuated the migration of ASCs. In conclusion, the present study is the first, to the best of our knowledge, to report that ROS generation and miR‑210 expression are associated with the LPA‑induced stimulation of ASCs, and that Serpine1 mediates the LPA‑induced migration of ASCs. These results further suggest that LPA may be used for ASC stimulation during stem cell expansion.

Citing Articles

NADPH Oxidase 3: Beyond the Inner Ear.

Herb M Antioxidants (Basel). 2024; 13(2).

PMID: 38397817 PMC: 10886416. DOI: 10.3390/antiox13020219.


Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?.

Yin C, Harms A, Hankemeier T, Kindt A, de Lange E Int J Mol Sci. 2023; 24(5).

PMID: 36902391 PMC: 10003384. DOI: 10.3390/ijms24054960.


Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells.

Kim D, Nam G, Seo E, Jun H J Biomed Sci. 2022; 29(1):31.

PMID: 35538534 PMC: 9092836. DOI: 10.1186/s12929-022-00814-1.


The ATX-LPA Axis Regulates Vascular Permeability during Cerebral Ischemic-Reperfusion.

Bhattarai S, Sharma S, Subedi U, Ara H, Shum A, Milena M Int J Mol Sci. 2022; 23(8).

PMID: 35456953 PMC: 9024554. DOI: 10.3390/ijms23084138.


Targeting lysophosphatidic acid receptor with Ki16425 impedes T cell lymphoma progression through apoptosis induction, glycolysis inhibition, and activation of antitumor immune response.

Gupta V, Kumar A Apoptosis. 2022; 27(5-6):382-400.

PMID: 35366141 DOI: 10.1007/s10495-022-01723-2.